Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Two publications.

Öngen Z.

Anatol J Cardiol. 2017 Jun;17(6):419-420. doi: 10.14744/AnatolJCardiol.2017.06. No abstract available.

2.

Multiple testing in the 'Canakinumab in atherosclerosis' trial: correction required?

Guzelant G, Ongen Z.

Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 104(2):24. Epub 2017 Apr 27.

3.

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.

Lincoff AM, Nicholls SJ, Riesmeyer JS, Barter PJ, Brewer HB, Fox KAA, Gibson CM, Granger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Wolski K, Ruotolo G, Vangerow B, Weerakkody G, Goodman SG, Conde D, McGuire DK, Nicolau JC, Leiva-Pons JL, Pesant Y, Li W, Kandath D, Kouz S, Tahirkheli N, Mason D, Nissen SE; ACCELERATE Investigators.

N Engl J Med. 2017 May 18;376(20):1933-1942. doi: 10.1056/NEJMoa1609581.

PMID:
28514624
4.

[33 Questions about Triglycerides and Cardiovascular Effects: Expert Answers].

Çetinkalp Ş, Koylan N, Özer N, Onat A, Özgen AG, Koldaş ZL, Sain Güven G, Özdoğan Ö, Karşıdağ K, Yiğit Z, Kayıkçıoğlu M, Tokgözoğlu L, Can LH, Tartan Z, Kültürsay H, Karpuz B, Kırılmaz B, Ersanlı M, Ural D, Erbakan AN, Oğuz A, Kayıkçıoğlu ÖR, Temizhan A, Sansoy V, Ceyhan C, Öngen Z, Bayram F, Örem C, Sönmez A, Beyaz Ş, Ükinç K, Şarer Yürekli B, Çoker M, Canda E, Yıldırım Şimşir I.

Turk Kardiyol Dern Ars. 2017 Mar;45(Suppl 1):1-63. doi: 10.5543/tkda.2017.77459. Turkish. No abstract available.

5.

Study titles.

Öngen Z.

Anatol J Cardiol. 2017 Mar;17(3):167. doi: 10.14744/AnatolJCardiol.2017.03. No abstract available.

6.

Thoughts provoked by this issue.

Öngen Z.

Anatol J Cardiol. 2017 Feb;17(2):81. doi: 10.14744/AnatolJCardiol.2017.02. No abstract available.

7.

Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials.

Kızılırmak P, Üresin Y, Özdemir O, Kılıçkıran Avcı B, Tokgözoğlu L, Öngen Z.

Turk Kardiyol Dern Ars. 2017 Jan;45(1):49-66. doi: 10.5543/tkda.2016.78006.

8.

A citation map.

Öngen Z.

Anatol J Cardiol. 2016 Dec;16(12):899. doi: 10.14744/AnatolJCardiol.2016.12. No abstract available.

9.

Retraction and Beyond.

Öngen Z.

Anatol J Cardiol. 2016 Nov;16(11):819. doi: 10.14744/AnatolJCardiol.2016.11. No abstract available.

10.

Rome and ESC 2016.

Öngen Z.

Anatol J Cardiol. 2016 Oct;16(10):773. doi: 10.14744/AnatolJCardiol.2016.10. No abstract available.

11.

Cardiologists and diabetes.

Öngen Z.

Anatol J Cardiol. 2016 Sep;16(9):647. doi: 10.14744/AnatolJCardiol.2016.09. No abstract available.

12.

Cost of heart failure management in Turkey: results of a Delphi Panel.

Aras D, Aydoğdu S, Bozkurt E, Çavuşoğlu Y, Eren M, Erol Ç, Güleç S, Kızılırmak P, Öngen Z, Özdemir O, Saylan M, Tokgözoğlu L, Yeter E, Yılmaz MB.

Anatol J Cardiol. 2016 Aug;16(8):554-62. doi: 10.14744/AnatolJCardiol.2016.6999.

13.

Relation between serum sodium levels and clinical outcomes in Turkish patients hospitalized for heart failure: a multi-center retrospective observational study.

Avcı BK, Küçük M, Müderrisoğlu H, Eren M, Kutlu M, Yılmaz MB, Çavuşoğlu Y, Öngen Z.

Anatol J Cardiol. 2017 Jan;17(1):2-7. doi: 10.14744/AnatolJCardiol.2016.6950. Epub 2016 Jul 21.

14.

Pre- and in-hospital antithrombotic management patterns and in-hospital outcomes in patients with acute coronary syndrome: data from the Turkish arm of the EPICOR study.

Ertaş FS, Tokgözoğlu L; EPICOR Study Group.

Anatol J Cardiol. 2016 Dec;16(12):900-915. doi: 10.14744/AnatolJCardiol.2016.6755. Epub 2016 Jun 29.

15.

Someone is following us, aren't they?

Öngen Z.

Anatol J Cardiol. 2016 Jul;16(7):459. doi: 10.14744/AnatolJCardiol.2016.07. No abstract available.

16.

Circulating miR-221-3p as a novel marker for early prediction of acute myocardial infarction.

Coskunpinar E, Cakmak HA, Kalkan AK, Tiryakioglu NO, Erturk M, Ongen Z.

Gene. 2016 Oct 10;591(1):90-6. doi: 10.1016/j.gene.2016.06.059. Epub 2016 Jun 30.

PMID:
27374153
17.

This month in the journal: cardiology and other disciplines.

Öngen Z.

Anatol J Cardiol. 2016 Jun;16(6):369. doi: 10.14744/AnatolJCardiol.2016.06. No abstract available.

18.

Chicago Spring and ACC.16.

Öngen Z.

Anatol J Cardiol. 2016 May;16(5):305. doi: 10.14744/AnatolJCardiol.2016.05. No abstract available.

19.

The waiting period.

Öngen Z.

Anatol J Cardiol. 2016 Apr;16(4):233. doi: 10.14744/AnatolJCardiol.2016.04. No abstract available.

20.

Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists.

Fitzmaurice DA, Accetta G, Haas S, Kayani G, Lucas Luciardi H, Misselwitz F, Pieper K, Ten Cate H, Turpie AG, Kakkar AK; GARFIELD-AF Investigators.

Br J Haematol. 2016 Aug;174(4):610-23. doi: 10.1111/bjh.14084. Epub 2016 Apr 12.

PMID:
27071942

Supplemental Content

Loading ...
Support Center